Providing the industry’s first commercially available high-parameter immune monitoring solution for deep profiling of PBMC, Fluidigm brings proven mass cytometry together with innovative third-party data analysis SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Maxpar® Human Immune Monitoring Panel Kit for comprehensive immune cell profiling in cancer and immune-mediated diseases. Immune […]
Lincoln, Nebraska: LI-COR Biosciences is pleased to announce that HS Biosystems is appointed to distribute LI-COR Biotechnology Products in Korea effective May 1, 2018. “The team at HS Biosystems offers qualified service and support personnel who will maintain close communication with LI-COR and with customers in Korea to provide the best possible service experience for researchers,” […]
After the announcement of investing in 10 PacBio Sequel Systems in earlier 2018,Annoroad plans to increase its collaboration with Pacific Biosciences. The two parties plan to collaborate, based on PacBio’s SMRT® Sequencing technology, in the areas of plant & animal genome studies, basic research in human biomedical sciences and translational medicine. In 2017, Annoroad declared its […]
The Genoox Integrated Platform is Designed to Offer Solutions for Combining Genoox Technology for Aligning and Calling NGS Short-Reads with Bionano Genome Mapping Technology to Better Understand Complexities of DNA Mutations SAN FRANCISCO–Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and […]
–Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week– PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, today launched the Chromium Single Cell CNV Solution, which is the first scalable and easy-to-use technology for rapid and massively parallel profiling of single cell […]
Expands Illumina’s Oncology Offerings for NextSeq™ 550Dx A Diagnostic Version of the Illumina TruSight™ Oncology 500 Assay Will Measure Potentially Predictive Genomic Biomarkers, Including Tumor Mutation Burden NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally […]
– Developing systems for single-cell analysis and promoting their use in drug R&D and life-science studies – Yokogawa Electric Corporation (TOKYO: 6841) announces the establishment on April 1 of a Single Cellome*1 Co-innovators’ Consortium with research groups led by Professor Kenichiro Todoroki and Assistant Professor Hajime Mizuno of the Laboratory of Analytical and Bioanalytical Chemistry, School […]
Tokyo, Japan – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare its priority. Amid […]
Scientists in North America can now benefit from the high contrast, label-free, live cell imaging provided by Livecyte™, following the appointment of Bulldog Bio as the Phasefocus™ distributor for USA and Canada. This announcement signals the start of an exciting time for Phasefocus, as the company seeks to make headway on its initial achievements and […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next-generation sequencing (NGS) library prep workflow for sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Cystic fibrosis (CF) is a complex, multisystem disease that is caused by mutations in the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
